![Multiple Sclerosis and related disorders - MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University Multiple Sclerosis and related disorders - MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University](https://cardiff.imgix.net/__data/assets/image/0003/125607/Neuron-Network.jpg?w=575&ar=16:9&q=80&auto=format)
Multiple Sclerosis and related disorders - MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University
![Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E](https://pubs.rsc.org/image/article/2020/NJ/c9nj06202e/c9nj06202e-f1_hi-res.gif)
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
![PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/73260542/mini_magick20211020-28066-1mffmro.png?1634799542)
PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
Bilateral cerebellar ataxia as the sole manifestation of a unilateral rostral pontine tegmental infarct Identification of amoeba
This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: https://orca.cardiff.ac.uk/
![Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00037/article_deploy/html/images/pharmaceuticals-14-00037-g001.png)
Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML
![Complement, a target for therapy in inflammatory and degenerative diseases | Nature Reviews Drug Discovery Complement, a target for therapy in inflammatory and degenerative diseases | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd4657/MediaObjects/41573_2015_Article_BFnrd4657_Fig1_HTML.jpg)